No Photo Available

Last Update

2017-03-10T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Allison Wey?

Ms. Allison H. Wey

Vice President, Investor Relations and Corporate Communications

Regulus Therapeutics Inc.

HQ Phone: (888) 734-8587

Email: a***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Regulus Therapeutics Inc.

3545 John Hopkins Court

San Diego, California 92121

United States

Company Description

Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well ... more

Find other employees at this company (118)

Background Information

Employment History

Vice President

Investor Relations & Corporate Communications

Vice President, Investor Relations and Public Affairs

Durata Therapeutics Inc

Vice President, Investor Relations and Corporate Affairs

Par Pharmaceutical Companies , Inc.

Vice President, Investor Relations

Boron , Lepore & Associates , Inc.

Senior Vice President

Edelman Inc

Managing Director, Financial Communications

Hill & Knowlton Inc

Associate Director, Equity Capital Markets

The Bear Stearns Companies Inc.

Trading Floor Reporter

American Stock Exchange LLC

Education

BA

Economics/Marketing

Drake University

Web References (92 Total References)


Allison Wey - Regulus Therapeutics

regulusrx.com [cached]

Allison Wey Vice President, Investor Relations and Corporate Communications

...
Allison Wey Vice President, Investor Relations and Corporate Communications
...
Allison Wey
...
In May, 2016, Allison Wey was appointed Vice President, Investor Relations and Corporate Communications for Regulus Therapeutics. Ms. Wey brings over 25 years of experience in investor relations, corporate communications, media relations, and investment banking. Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG. Ms. Wey also worked in media relations and corporate communications leadership roles including VP, Investor Relations at Boron, LePore & Associates, Senior VP at Edelman Financial Worldwide, Managing Director, Financial Communications at Hill & Knowlton, and Associate Director, Equity Capital Markets at Bear, Stearns & Co. Inc.


Dan Chevallard - Regulus Therapeutics

regulusrx.com [cached]

Allison Wey Vice President, Investor Relations and Corporate Communications

...
Allison Wey Vice President, Investor Relations and Corporate Communications


Leadership Updates

www.leadershipdirectories.com [cached]

Regulus Therapeutics, Inc. appointed Allison Wey Vice President of Investor Relations and Corporate Communications.


Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications - Regulus Therapeutics Inc.

ir.regulusrx.com [cached]

Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications


Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications (NASDAQ:RGLS)

ir.regulusrx.com [cached]

Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications | Previous Release Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications (NASDAQ:RGLS) Facebook

...
Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications
...
Allison Wey has been appointed Vice President, Investor Relations and Corporate Communications
Ms. Wey
...
"We are pleased to welcome Allison, and we look forward to her contributions in communicating the strong potential of Regulus' pipeline."
"Regulus is leading the way in developing important new therapies focused on microRNA dysregulation to treat a wide range of diseases," said Allison Wey . "I'm excited to join the Regulus team in advancing its broad portfolio."
Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG. Ms. Wey

Similar Profiles

Other People with this Name

Other people with the name Wey

Margaret Wey
Massachusetts General Hospital

Rebecca Wey
Lee Equity Partners LLC

Alicia De Wey
Caesars Entertainment Corporation

Dan Wey
Acres

Tony Wey
CliftonLarsonAllen LLP

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory